Navigation Links
A pocketful of uranium
Date:2/12/2009

This release is available in German.

The use of uranium as a nuclear fuel and in weapons increases the risk that people may come into contact with it, and the storage of radioactive uranium waste poses an additional environmental risk. However, radioactivity is not the only problem related to contact with uranium; the toxicity of this metal is generally more dangerous to human health. Researchers are still looking for simple, effective methods for the sensitive detection and effective treatment of uranium poisoning. Researchers led by Chuan He at the University of Chicago and Argonne National Laboratory (USA) have now developed a protein that binds to uranium selectively and tightly. As reported in the journal Angewandte Chemie, it is based on a bacterial nickel-binding protein.

In oxygen-containing, aqueous environments, uranium normally exists in the form of the uranyl cation (UO22+), a linear molecule made of one uranium atom and two terminal oxygen atoms. The uranyl ion also likes to form coordination complexes. It prefers to surround itself with up to six ligands arranged in a plane around the ion's "equator". The research team thus chose to develop a protein that offers the uranyl ion a binding cavity in which it is surrounded by the protein's side-groups in the manner it prefers.

As a template, the scientists used the protein NikR (nickel-responsive repressor) from E. coli, a regulator that reacts to nickel ions. When NikR is loaded with nickel ions, it binds to a special DNA sequence. This represses transcription of the neighboring genes, which code for proteins involved in nickel uptake. If no nickel is present in the bacteria, NikR does not bind to the DNA.

The nickel ion is located in a binding cavity in which it is surrounded by a square-planar arrangement of binding groups. By using several mutation steps, the researchers generated a new protein that can bind uranium instead of nickel. Only three amino acids had to be changed. In the specially designed cavity, the uranyl group has six binding partners that surround it equatorially. In addition, there are spaces for the two terminal oxygen atoms of uranyl.

This NikR mutant only binds to DNA in the presence of uranyl, not in the presence of nickel or other metal ions. This confirms its selectivity for uranyl and may make it useful for the detection of uranyl and nuclear waste bioremediation. It also represents the first step towards developing potential protein- or peptide-based agents for treatment of uranium poisoning.


'/>"/>

Contact: Chuan He
chuanhe@uchicago.edu
773-702-5061
Wiley-Blackwell
Source:Eurekalert  

Related biology news :

1. Major source of radon exposure overlooked at former Ohio uranium-processing plant
2. Sophisticated monitoring array to address mystery of uranium plume
3. Fungi have a hand in depleted uraniums environmental fate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A pocketful of uranium
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: